APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Allergy Immunotherapies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

Selected research

Market Structure

Global Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173893490326 December 2025173 pages

Choose your research edition.

Industry ResearchAllergy Immunotherapies Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergy Immunotherapies Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Allergy Immunotherapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergy Immunotherapies Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergy Immunotherapies Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.

Read the full market overview

Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.

In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.

Report Includes

This report provides an overview of the global Allergy Immunotherapies market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Allergy Immunotherapies and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Allergy Immunotherapies revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Allergy Immunotherapies market size, projected growth trends, production technologies, key applications, and end-use industries.

Allergy Immunotherapies Segment by Company

ALK

Stallergenes

HAL

Allergy Immunotherapies Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Immunotherapies Segment by Application

Allergic Rhinitis

Allergic Asthma

Other

Allergy Immunotherapies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Allergy Immunotherapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Allergy Immunotherapies industry.

Chapter 3: Detailed analysis of Allergy Immunotherapies companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Immunotherapiesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Allergy Immunotherapies Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Subcutaneous Immunotherapy Table 3. Key Players of Sublingual Immunotherapy Table 4. Global Allergy Immunotherapies Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Allergic Rhinitis Table 6. Key Players of Allergic Asthma Table 7. Key Players of Other Table 8. Global Allergy Immunotherapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Allergy Immunotherapies Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Allergy Immunotherapies Market Share by Region (2021-2026) Table 11. Global Allergy Immunotherapies Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Allergy Immunotherapies Market Share by Region (2027-2032) Table 13. Allergy Immunotherapies Industry Trends Table 14. Allergy Immunotherapies Industry Drivers Table 15. Allergy Immunotherapies Industry Opportunities and Challenges Table 16. Allergy Immunotherapies Industry Restraints Table 17. Global Allergy Immunotherapies Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Allergy Immunotherapies Revenue Market Share by Company (2021-2026) Table 19. Global Allergy Immunotherapies Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Allergy Immunotherapies Key Company Head Office and Area Served Table 21. Global Allergy Immunotherapies Company, Product Type & Application Table 22. Global Allergy Immunotherapies Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Allergy Immunotherapies Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Allergy Immunotherapies Revenue Market Share by Type (2021-2026) Table 29. Global Allergy Immunotherapies Revenue Market Share by Type (2027-2032) Table 30. Global Allergy Immunotherapies Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Allergy Immunotherapies Revenue Market Share by Application (2021-2026) Table 34. Global Allergy Immunotherapies Revenue Market Share by Application (2027-2032) Table 35. ALK Company Information Table 36. ALK Business Overview Table 37. ALK Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ALK Allergy Immunotherapies Product Portfolio Table 39. ALK Recent Development Table 40. Stallergenes Company Information Table 41. Stallergenes Business Overview Table 42. Stallergenes Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Stallergenes Allergy Immunotherapies Product Portfolio Table 44. Stallergenes Recent Development Table 45. HAL Company Information Table 46. HAL Business Overview Table 47. HAL Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. HAL Allergy Immunotherapies Product Portfolio Table 49. HAL Recent Development Table 50. North America Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 51. North America Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 52. North America Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 53. North America Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 54. North America Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 55. North America Allergy Immunotherapies Market Size by Country (2021-2026) Table 56. North America Allergy Immunotherapies Market Size by Country (2027-2032) Table 57. Europe Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 58. Europe Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 59. Europe Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 60. Europe Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 61. Europe Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 62. Europe Allergy Immunotherapies Market Size by Country (2021-2026) Table 63. Europe Allergy Immunotherapies Market Size by Country (2027-2032) Table 64. China Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 65. China Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 66. China Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 67. China Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 68. Asia Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 69. Asia Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 70. Asia Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 71. Asia Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 72. Asia Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Asia Allergy Immunotherapies Market Size by Country (2021-2026) Table 74. Asia Allergy Immunotherapies Market Size by Country (2027-2032) Table 75. South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2021-2026) & (US$ Million) Table 76. South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2027-2032) & (US$ Million) Table 77. South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2021-2026) & (US$ Million) Table 78. South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2027-2032) & (US$ Million) Table 79. South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2021-2026) Table 81. South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2027-2032) Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Allergy Immunotherapies Product Image Figure 2. Global Allergy Immunotherapies Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Allergy Immunotherapies Market Share by Type: 2025 VS 2032 Figure 4. Subcutaneous Immunotherapy Image Figure 5. Sublingual Immunotherapy Image Figure 6. Global Allergy Immunotherapies Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Allergy Immunotherapies Market Share by Application: 2025 VS 2032 Figure 8. Allergic Rhinitis Image Figure 9. Allergic Asthma Image Figure 10. Other Image Figure 11. Global Allergy Immunotherapies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 13. Global Allergy Immunotherapies Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Allergy Immunotherapies Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Allergy Immunotherapies Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Allergy Immunotherapies Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Allergy Immunotherapies Revenue Market Share by Type (2021-2032) Figure 20. Global Allergy Immunotherapies Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Allergy Immunotherapies Revenue Market Share by Application (2021-2032) Figure 22. North America Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 23. North America Allergy Immunotherapies Market Share by Type (2021-2032) Figure 24. North America Allergy Immunotherapies Market Share by Application (2021-2032) Figure 25. North America Allergy Immunotherapies Market Share by Country (2021-2032) Figure 26. United States Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 27. Canada Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 29. Europe Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 30. Europe Allergy Immunotherapies Market Share by Type (2021-2032) Figure 31. Europe Allergy Immunotherapies Market Share by Application (2021-2032) Figure 32. Europe Allergy Immunotherapies Market Share by Country (2021-2032) Figure 33. Germany Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 34. France Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 36. Italy Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 37. Russia Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 39. China Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 40. China Allergy Immunotherapies Market Share by Type (2021-2032) Figure 41. China Allergy Immunotherapies Market Share by Application (2021-2032) Figure 42. Asia Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 43. Asia Allergy Immunotherapies Market Share by Type (2021-2032) Figure 44. Asia Allergy Immunotherapies Market Share by Application (2021-2032) Figure 45. Asia Allergy Immunotherapies Market Share by Country (2021-2032) Figure 46. Japan Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 50. India Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 51. Australia Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Allergy Immunotherapies Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Allergy Immunotherapies Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Allergy Immunotherapies Market Share by Country (2021-2032) Figure 56. Brazil Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 61. UAE Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 63. Chile Allergy Immunotherapies Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Companies covered
  • ALK
  • Stallergenes
  • HAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Immunotherapy
  5. 1.2.3 Sublingual Immunotherapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Allergy Immunotherapies Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Allergic Rhinitis
  9. 1.3.3 Allergic Asthma
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Allergy Immunotherapies Growth Trends by Region
  13. 1.5.1 Global Allergy Immunotherapies Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Allergy Immunotherapies Market Size by Region (2021-2026)
  15. 1.5.3 Allergy Immunotherapies Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Allergy Immunotherapies Market Dynamics
  1. 2.1 Allergy Immunotherapies Industry Trends
  2. 2.2 Allergy Immunotherapies Industry Drivers
  3. 2.3 Allergy Immunotherapies Industry Opportunities and Challenges
  4. 2.4 Allergy Immunotherapies Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Allergy Immunotherapies Revenue by Company (2021-2026)
  2. 3.2 Global Allergy Immunotherapies Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Allergy Immunotherapies Key Company Head office and Area Served
  4. 3.4 Global Allergy Immunotherapies Company, Product Type & Application
  5. 3.5 Global Allergy Immunotherapies Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Allergy Immunotherapies Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Allergy Immunotherapies Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Allergy Immunotherapies Tier 1, Tier 2, and Tier 3
4 Allergy Immunotherapies Market by Type
  1. 4.1 Global Allergy Immunotherapies Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Allergy Immunotherapies Market Size by Type (2021-2032)
  3. 4.3 Global Allergy Immunotherapies Market Size Share by Type (2021-2032)
5 Allergy Immunotherapies Market by Application
  1. 5.1 Global Allergy Immunotherapies Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Allergy Immunotherapies Market Size by Application (2021-2032)
  3. 5.3 Global Allergy Immunotherapies Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ALK
  2. 6.1.1 ALK Company Information
  3. 6.1.2 ALK Business Overview
  4. 6.1.3 ALK Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ALK Allergy Immunotherapies Product Portfolio
  6. 6.1.5 ALK Recent Developments
  7. 6.2 Stallergenes
  8. 6.2.1 Stallergenes Company Information
  9. 6.2.2 Stallergenes Business Overview
  10. 6.2.3 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
  12. 6.2.5 Stallergenes Recent Developments
  13. 6.3 HAL
  14. 6.3.1 HAL Company Information
  15. 6.3.2 HAL Business Overview
  16. 6.3.3 HAL Allergy Immunotherapies Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 HAL Allergy Immunotherapies Product Portfolio
  18. 6.3.5 HAL Recent Developments
7 North America
  1. 7.1 North America Allergy Immunotherapies Market Size (2021-2032)
  2. 7.2 North America Allergy Immunotherapies Market Size by Type
  3. 7.2.1 North America Allergy Immunotherapies Market Size by Type (2021-2026)
  4. 7.2.2 North America Allergy Immunotherapies Market Size by Type (2027-2032)
  5. 7.2.3 North America Allergy Immunotherapies Market Share by Type (2021-2032)
  6. 7.3 North America Allergy Immunotherapies Market Size by Application
  7. 7.3.1 North America Allergy Immunotherapies Market Size by Application (2021-2026)
  8. 7.3.2 North America Allergy Immunotherapies Market Size by Application (2027-2032)
  9. 7.3.3 North America Allergy Immunotherapies Market Share by Application (2021-2032)
  10. 7.4 North America Allergy Immunotherapies Market Size by Country
  11. 7.4.1 North America Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Allergy Immunotherapies Market Size by Country (2021-2026)
  13. 7.4.3 North America Allergy Immunotherapies Market Size by Country (2027-2032)
  14. 7.4.4 North America Allergy Immunotherapies Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Allergy Immunotherapies Market Size (2021-2032)
  2. 8.2 Europe Allergy Immunotherapies Market Size by Type
  3. 8.2.1 Europe Allergy Immunotherapies Market Size by Type (2021-2026)
  4. 8.2.2 Europe Allergy Immunotherapies Market Size by Type (2027-2032)
  5. 8.2.3 Europe Allergy Immunotherapies Market Share by Type (2021-2032)
  6. 8.3 Europe Allergy Immunotherapies Market Size by Application
  7. 8.3.1 Europe Allergy Immunotherapies Market Size by Application (2021-2026)
  8. 8.3.2 Europe Allergy Immunotherapies Market Size by Application (2027-2032)
  9. 8.3.3 Europe Allergy Immunotherapies Market Share by Application (2021-2032)
  10. 8.4 Europe Allergy Immunotherapies Market Size by Country
  11. 8.4.1 Europe Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Allergy Immunotherapies Market Size by Country (2021-2026)
  13. 8.4.3 Europe Allergy Immunotherapies Market Size by Country (2027-2032)
  14. 8.4.4 Europe Allergy Immunotherapies Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Allergy Immunotherapies Market Size (2021-2032)
  2. 9.2 China Allergy Immunotherapies Market Size by Type
  3. 9.2.1 China Allergy Immunotherapies Market Size by Type (2021-2026)
  4. 9.2.2 China Allergy Immunotherapies Market Size by Type (2027-2032)
  5. 9.2.3 China Allergy Immunotherapies Market Share by Type (2021-2032)
  6. 9.3 China Allergy Immunotherapies Market Size by Application
  7. 9.3.1 China Allergy Immunotherapies Market Size by Application (2021-2026)
  8. 9.3.2 China Allergy Immunotherapies Market Size by Application (2027-2032)
  9. 9.3.3 China Allergy Immunotherapies Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Allergy Immunotherapies Market Size (2021-2032)
  2. 10.2 Asia Allergy Immunotherapies Market Size by Type
  3. 10.2.1 Asia Allergy Immunotherapies Market Size by Type (2021-2026)
  4. 10.2.2 Asia Allergy Immunotherapies Market Size by Type (2027-2032)
  5. 10.2.3 Asia Allergy Immunotherapies Market Share by Type (2021-2032)
  6. 10.3 Asia Allergy Immunotherapies Market Size by Application
  7. 10.3.1 Asia Allergy Immunotherapies Market Size by Application (2021-2026)
  8. 10.3.2 Asia Allergy Immunotherapies Market Size by Application (2027-2032)
  9. 10.3.3 Asia Allergy Immunotherapies Market Share by Application (2021-2032)
  10. 10.4 Asia Allergy Immunotherapies Market Size by Country
  11. 10.4.1 Asia Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Allergy Immunotherapies Market Size by Country (2021-2026)
  13. 10.4.3 Asia Allergy Immunotherapies Market Size by Country (2027-2032)
  14. 10.4.4 Asia Allergy Immunotherapies Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Allergy Immunotherapies Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Allergy Immunotherapies Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Allergy Immunotherapies Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Allergy Immunotherapies Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Allergy Immunotherapies Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst